The World-Changing Science of Organ Manufacturing w/ Dean Kamen | EP #100
Inventor Dean Kamen walks Peter Diamandis through three of his moonshots: ARMI (Advanced Regenerative Manufacturing Institute, branded 'Regen Valley'), a DOD-funded effort to industrialize manufacturing of human cells, tissues, and organs from a patient's own iPSCs, including a portable organ life-support 'Pod' and progress on kidneys, lungs, hearts, islet cells, and a retinal implant for macular degeneration. He also unveils Daisy, a semiconductor-fabricated microneedle patch that delivers vaccines intradermally at roughly one-tenth the dose with no needle/syringe waste, developed in response to COVID-19 vaccine manufacturing bottlenecks. The episode closes on FIRST and FIRST Global, Kamen's 32-year-old robotics nonprofit movement, including the story of 191 countries signing a 'Declaration of Interdependence and Bill of Responsibilities' during the 2023 Singapore event, which coincided with the Hamas attack on Israel. Along the way Kamen recounts the decades-long fight to get the iBOT self-balancing wheelchair reclassified by the FDA. Two sponsor reads (Fountain Life, Viome) are embedded mid-episode.
iBOT self-balancing wheelchair and its FDA reclassification fightHealth▶ 1:08
Kamen describes building the iBOT (using gyros, accelerometers, and control systems from helicopters/autopilots) to restore dignity and eye-level interaction for wheelchair users, the FDA's initial refusal to even review it, and the eventual data-driven reclassification from Class III to Class II after 10+ million field hours with zero system failures.
ARMI is a DOD-funded nonprofit institute in Manchester, NH (repurposed Amoskeag textile mills) building the industrial infrastructure -- akin to Silicon Valley for semiconductors -- to mass-manufacture human cells, tissues, and organs from patients' own induced pluripotent stem cells (iPSCs).
Closed-loop artificial pancreas / insulin pump FDA approvalHealth▶ 9:08
Kamen reveals that on the morning of the interview the FDA approved DEKA's closed-loop, no-moving-parts insulin pump with integrated glucose sensing -- effectively an artificial pancreas -- roughly a decade in development.
$100M new ARMI grant and DOD/White House backingBiotech▶ 9:57
ARMI received official confirmation of a new $100 million federal grant (bringing total funding past $200 million), following an initial $80 million from the Department of Defense about six years earlier; the Manchester Millyard was later declared by President Biden, via the Economic Development Administration, the national 'epicenter of Regen Valley.'
Manufactured organs pipeline: retina implants, islet cells, and heartsBiotech▶ 15:41
ARMI/DEKA are developing a millimeter-scale retinal implant for macular degeneration nearing FDA submission, mass-producing pancreatic islet/beta cells in bioreactors (billions per day) in partnership with JDRF for distribution to researchers nationwide, and building pediatric-sized hearts (building on Doris Taylor's decellularized/recellularized pig heart work) slated for animal testing in 2024.
The 'Pod' -- portable organ life-support and transport systemBiotech▶ 24:53
A DEKA spinout building a mobile life-support pod that keeps organs (demonstrated with cadaveric kidneys) alive and improving for days outside the body, with plans to integrate with Beta Technologies' eVTOL aircraft for rapid organ delivery; the FDA granted the device breakthrough status.
Born from COVID-19 vaccine manufacturing/logistics bottlenecks, Daisy uses semiconductor-fabricated microneedle wafers to deliver vaccines directly into the skin's dendritic-cell-rich layer rather than through it, requiring roughly one-tenth the dose, eliminating needles/syringes/trained clinicians, and causing no pain.
Origins and philosophy of FIRST roboticsOther▶ 43:47
Kamen founded FIRST 32 years ago on the belief that America's shortage of engineers was a 'culture crisis,' not an 'education crisis' -- kids need superheroes in science the way they have them in sports -- and grew it from 23 teams to tens of thousands of schools with a new sub-$100 classroom robotics kit now standard in New Hampshire.
FIRST Global: international robotics competitionGeopolitics▶ 52:56
At Shimon Peres's urging, Kamen founded FIRST Global to bring one robotics team from every country in the world together annually (Washington DC, Mexico City, Dubai, Geneva, Singapore), including a team of stateless Syrian refugee children ('Team Hope').
Declaration of Interdependence and Bill of Responsibilities signed amid the Hamas attack on IsraelGeopolitics▶ 59:37
At the 2023 FIRST Global event in Singapore, opening ceremonies (including Iran, Iraq, and Israel walking together) coincided with the October 7 Hamas attack; by the close of the event, all 191 participating countries had signed newly drafted 'Declaration of Interdependence' and 'Bill of Responsibilities' documents.
Predictions made
openDean Kamen: ARMI will be in clinical trials with half a dozen different ARMI-based organ/tissue products.
EP #? · · due: not specified (near-term, statement cuts off mid-sentence) · ▶ watch
“We will be in clinical trials with a half a dozen different Army based products within the next”
Your call:
openDean Kamen: A retinal implant device for macular degeneration, currently being tested in animals, will be in front of the FDA.
EP #? · · due: within a couple of years of May 2024 · ▶ watch
“I'm believing that within certainly a couple of years that will be in front of the FDA and your worries about macular degeneration may be substantially reduced.”
Your call:
openDean Kamen: DEKA/ARMI will put manufactured pediatric-sized hearts into animal trials.
“we will be putting some of these quote manufactured hearts in animals this year.”
Your call:
openDean Kamen: ARMI/DEKA-produced islet cells (billions per day from bioreactors) will begin being shipped to researchers around the country.
EP #? · · due: within a few months of May 2024 · ▶ watch
“we're starting to within the next few months we'll be shipping some of them around the country.”
Your call:
openDean Kamen: Kamen told the White House that ARMI would get an organ-manufacturing product in front of the FDA within five years of ARMI's founding (~2018), and that the U.S. would need a complete new regulatory strategy for organ manufacturing before then.
EP #? · · due: ~2023 (5 years from ARMI founding) · ▶ watch
“Even if we're lucky enough that within the 5 years I told you we'll get something in front of the FDA... Unless we start now, we'll be 5 years ahead of the FDA when we have the capacity to do this.”
Your call:
openDean Kamen: By the next pandemic, vaccine delivery in the U.S. will use needle-free intradermal devices like Daisy instead of syringes and needles, eliminating associated side effects.
EP #? · · due: next pandemic (unspecified date) · ▶ watch
“I'm hoping by the next time a pandemic hits this country, you won't have to see syringes and needles and large volumes and get fevers and muscle all the side effects go away.”
Your call:
openDean Kamen: FIRST Global will announce the host city, host country, and theme for its next annual event at a public unveiling at Meridian House in Washington, D.C.
“sketching right now, it will happen between September 26th and September 29th at the end of this year.”
Your call:
Numbers that matter
10+ million hoursiBOT fleet field operation time with zero single-system failures before FDA reclassification review
50 iBOT units / 2 per hospitalVeterans Administration accepted 50 iBOTs, 2 donated to each of 25 VA hospitals
16 yearsTime from iBOT development until CMS (Medicare/Medicaid) agreed to cover it, announced January 2024
80,000 square feetSize of the mill-yard building Martine Rothblatt's organization took over for lung and kidney manufacturing
$100 millionNew additional federal grant to ARMI confirmed the morning of this recording
$200+ million total / $80 million initialTotal ARMI capital to date vs. the original DOD grant ~6 years earlier
200,000 people / 20% die per yearNumber waiting for kidney transplants in the U.S. and annual mortality rate on the waiting list
200 member organizations / ~60 full-time employeesSize of the ARMI consortium (med schools, pharma companies, startups) and its core staff
a few billion islet cells per dayOutput of ARMI/DEKA bioreactors producing pancreatic islet/beta cells for JDRF-funded researchers
1/10th the doseReduction in required vaccine dose when delivered intradermally via Daisy vs. intramuscular injection
75,000 microneedles per waferDaisy's semiconductor-fabricated microneedle wafer, made on the same equipment used for computer chips
500 millionths of an inch / 100 millionths of an inchLength of Daisy's microneedles and the diameter of the needle bore, respectively
~20 parts / 2 lb of spring pressure / 2 minutesDaisy device part count, delivery pressure, and time to deliver a tenth-cc dose
700,000+ individuals testedNumber of people Viome (sponsor) has tested with its Full Body Intelligence product
36% / 40% / 30% / 48% reductionsViome-reported reductions in depression, anxiety, diabetes, and IBS respectively after 6 months, per American Journal of Lifestyle Medicine (sponsor claim)
Worth digging into
🕳️ ARMI / Regen Valley organ manufacturing timeline
If real, this is the first industrial-scale infrastructure for manufacturing personalized human organs from a patient's own iPSCs -- a potential end to transplant waiting lists.
🕳️ Daisy microneedle vaccine patch
A needle-free, one-tenth-dose intradermal vaccine delivery method could reshape pandemic response, global vaccine logistics, and manufacturing capacity requirements.
🕳️ The organ 'Pod' and Beta Technologies eVTOL organ delivery
Extending a cadaveric kidney's viable window from hours to days (and improving its function) plus rapid eVTOL delivery could eliminate transplant organ spoilage and much of the transport backlog.
🕳️ The 2023 FIRST Global Singapore event and the Declaration of Interdependence / Bill of Responsibilities
A striking real-world story of youth diplomacy: 191 countries, including Iran, Iraq, and Israel, signed cooperative documents during the exact days of the Hamas attack on Israel.
🕳️ Elon Musk's 'idea-to-manufacturing' ratio comment
Musk's framing -- that manufacturing difficulty, not the original invention, is where nearly all of the realized value/risk lives -- is a reusable mental model for evaluating any deep-tech moonshot.